最新公告列表 《尚纬股份有限公司获得政府补助的公告》 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 截至2025年12月12日收盘，尚纬股份（603333）报收于8.12元，较前一交易日上涨3.97%，最新总市值 为50.47亿元。该股当日开盘7.81元，最高8.27元，最低7.8元，成交额达1.5亿元，换手率为2.98%。 公司近日发布公告称，尚纬股份有限公司于2025年12月11日收到政府补助2,212,000元，为与收益相关的 政府补助，占公司2024年度经审计归属于上市公司股东净利润的13.53%。根据企业会计准则相关规 定，该补助预计将对公司2025年度利润产生一定积极影响。上述会计处理及损益影响最终以审计机构年 度审计确认结果为准。 ...

每经头条（nbdtoutiao）——实施城乡居民增收计划、降准降息等工具灵活高效运用、增加普通高中学 位……深度解读中央经济工作会议 （记者 王晓波） 截至发稿，尚纬股份市值为50亿元。 每经AI快讯，尚纬股份（SH 603333，收盘价：8.12元）12月12日晚间发布公告称，尚纬股份有限公司 于2025年12月11日收到政府补助约221万元，为与收益相关的政府补助，占公司2024年度经审计归属于 上市公司股东的净利润的13.53%。 2024年1至12月份，尚纬股份的营业收入构成为：制造业占比97.4%，其他业务占比2.6%。 ...

证券日报网讯 12月12日晚间，尚纬股份发布公告称，公司于2025年12月11日收到政府补助2，212，000 元，为与收益相关的政府补助，占公司2024年度经审计归属于上市公司股东的净利润的13.53%。 （文章来源：证券日报） ...

Group 1 - Shouyao Holdings is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries regarding the specifics of the listing [1] - Jiangsu Guoxin's subsidiary, Guoxin Mazhou, has completed the trial operation of a 1000MW coal-fired power unit, which is set to officially commence operations on December 12, 2025 [2] - Yuekang Pharmaceutical's mRNA tumor vaccine has received clinical trial approval from the National Medical Products Administration for treating advanced solid tumors [3] Group 2 - Dongli New Science plans to invest 666 million yuan in the restructuring of SAIC Hongyan, acquiring approximately 14.66% equity post-restructuring [4] - Longsheng Technology is set to invest approximately 350 million yuan in the establishment of an intelligent robot innovation center in Wuxi [5] - Shangwei Co. has received a government subsidy of 2.212 million yuan, which accounts for 13.53% of its audited net profit for 2024 [6] Group 3 - Anglikang has received drug registration certificates for Diclofenac Sodium Enteric-Coated Tablets and approval for a supplemental application for Sacubitril/Valsartan Sodium Tablets [7] - Guangzhou Development has received acceptance notices for the registration of 8 billion yuan in medium-term notes and 6 billion yuan in short-term financing bonds [8] - Kebo Da plans to increase capital by 21.2 million euros (approximately 174 million yuan) in its wholly-owned subsidiary in Germany [9][10] Group 4 - Changguang Huaxin has received a total of 11.6672 million yuan in government subsidies, including 8.0552 million yuan related to income [11] - Haizheng Pharmaceutical's subsidiary has received a European Pharmacopoeia suitability certificate for its raw material [12] - Qianjin Pharmaceutical's subsidiary has received a drug registration certificate for Lurasidone Hydrochloride Tablets, used for treating schizophrenia [13] Group 5 - Daimai Co. has received a warning letter from the Shanghai Securities Regulatory Bureau due to failure to timely disclose a significant event related to a fire incident [14] - ST Changyao's subsidiary has recently ceased production due to financial difficulties and competitive pressures in the photovoltaic industry [15] - Guodian Power is investing in the construction of a 2×1000MW expansion project at the Ganbi Power Plant, with a total dynamic investment of 7.218 billion yuan [16] Group 6 - Kaichuang International's subsidiary has completed the handover of a tuna purse seine vessel, expected to be operational by 2026 [16] - Tieke Rail plans to sign an energy management agreement for a distributed photovoltaic project, which is expected to save approximately 1.441 million yuan in electricity costs over 25 years [18] - Bailian Co. plans to sign a land compensation agreement with Friendship Logistics, with a total compensation of 103 million yuan [19] Group 7 - Dayu Water-saving's subsidiary has been pre-awarded two high-standard farmland construction projects, with total expected amounts of 137 million yuan and 135 million yuan respectively [20] - Tianma Technology reported a total eel output of approximately 1197.15 tons in November, with sales prices ranging from 53,000 yuan/ton to 89,000 yuan/ton [21] - Guorui Technology's subsidiary has been shortlisted for the GXLF project with a bid of 76 million yuan [22] Group 8 - Qingdao Food's deputy general manager has resigned for personal reasons [23] - Guosheng Zhike plans to use up to 900 million yuan of idle funds for cash management [24] - Guodian Nanrui plans to use up to 23 billion yuan of idle funds for entrusted wealth management [25] Group 9 - Jiahuan Energy plans to merge its wholly-owned subsidiary, Zhejiang Jiahuan Hydrogen Peroxide Co., Ltd., through an overall absorption merger [26] - Ganyue Expressway reported vehicle toll service revenue of 309 million yuan for November [27] - Jinling Hotel's chairman has resigned due to work changes [28] Group 10 - Lisheng Pharmaceutical's subsidiary has received drug registration certificates for Apremilast Tablets [29] - Baotai has received a positive opinion from the European Medicines Agency for Gotenfia® for various inflammatory conditions [30] - ST Zhisheng has been awarded a smart city governance project with a bid amount of 104 million yuan [31] Group 11 - Chenxi Aviation and its related personnel have received administrative regulatory measures from the Shaanxi Securities Regulatory Bureau due to financial reporting issues [32] - Portong Medical has appointed Xia Canglan as the new deputy general manager [33] - Maide Medical plans to repurchase shares with a total amount between 20 million and 40 million yuan [34] Group 12 - Jimin Health plans to establish a joint venture with a total investment of 600 million yuan, focusing on AI and software development [35] - Beilu Pharmaceutical has received a drug registration certificate for Pioglitazone Metformin Tablets [36] - Hainan Mining plans to entrust the overall management of the Shiluo Iron Mine to a construction company for three years, with a total contract amount of approximately 818 million yuan [38] Group 13 - Huiyu Pharmaceutical has received a drug registration certificate for Nicardipine Hydrochloride Injection [39] - Baoland has received a government subsidy of 10 million yuan related to income [40] - Qingdao Port has terminated the acquisition of 100% equity in an oil company and 50% equity in Rizhao Shihua due to regulatory concerns [41]

证券代码：603333 证券简称：尚纬股份 公告编号：临 2025-075 尚纬股份有限公司 获得政府补助的公告 根据《企业会计准则第 16 号——政府补助》的相关规定，公司上述获得的 政府补助为与收益相关的政府补助。预计上述政府补助对公司 2025 年度的利润 将产生一定的积极影响。 上述政府补助数据未经审计，具体的会计处理以及对公司 2025 年度损益的 影响，最终以审计机构年度审计确认后的结果为准。敬请投资者注意投资风险。 特此公告。 尚纬股份有限公司董事会 二〇二五年十二月十三日 1 尚纬股份有限公司（以下简称"公司"）于 2025 年 12 月 11 日收到政府补助 2,212,000 元，为与收益相关的政府补助，占公司 2024 年度经审计归属于上市公 司股东的净利润的 13.53%。 二、补助的类型及其对上市公司的影响 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、获得补助的基本情况 ...

格隆汇12月12日丨尚纬股份(603333.SH)公布，公司于2025年12月11日收到政府补助221.2万元，为与收 益相关的政府补助，占公司2024年度经审计归属于上市公司股东的净利润的13.53%。 ...

人民财讯12月12日电，尚纬股份（603333）12月12日公告，公司于2025年12月11日收到政府补助221.2 万元，为与收益相关的政府补助，占公司2024年度经审计归属于上市公司股东的净利润的13.53%。 ...

尚纬股份公告称，公司于2025年12月11日收到政府补助221.2万元，为与收益相关的政府补助，占公司 2024年度经审计归属于上市公司股东的净利润的13.53%。根据会计准则，该补助预计对公司2025年度 利润产生一定积极影响。补助数据未经审计，具体会计处理及对损益的影响以审计结果为准。 ...

12月10日盘后，尚纬股份发布公告，公司增资控股四川中氟泰华新材料科技有限公司（下称"中氟泰 华"）事项获通过，增资完成后将持有中氟泰华51%的股权。这意味着尚纬股份"电缆+化学品"双轮驱动 战略正式启航。 此次投资，是尚纬股份在夯实特色电缆主营业务的基础上做出的战略布局。中氟泰华主营电子化学品及 相关基础化学品，广泛应用于集成电路、新能源电池材料等战略性新兴产业领域，不仅顺应国家战略， 也契合了区域产业布局。 "十五五"规划建议提出培育壮大新兴产业和未来产业，其中强调加快新能源、新材料、航空航天、低空 经济等战略性新兴产业集群发展。这次投资精准契合了乐山市打造千亿级绿色化工产业集群的发展方 向，是乐山市深化产业转型升级、构建"241"现代工业体系的重要实践。 将形成"1+1>2"协同效应 从特种电缆到化学品，尚纬股份意在打造第二增长极，双轮驱动战略正式形成，有望形成"1+1>2"的协 同效应。 尚纬股份是西南地区最大的特种电缆企业之一，经过长期耕耘，在特种电缆领域已建立起较大优势和影 响力。主要产品包括核电站用电缆、轨道交通用电缆、中压交联电缆、高压电力电缆、太阳能光伏发电 用电缆、矿用电缆、船用电缆、风力 ...

证券代码：603333 证券简称：尚纬股份 公告编号：2025-074 尚纬股份有限公司 2025年第三次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 本次会议是否有否决议案：无 一、会议召开和出席情况 (一)股东会召开的时间：2025年12月10日 ■ 注：出席会议的股东所持有表决权股份数占公司有表决权股份总数（扣除回购账户股份数）的比例为 27.70% (四)表决方式是否符合《公司法》及《公司章程》的规定，会议主持情况等。 本次会议由公司董事会召集，公司董事长叶洪林主持。本次会议的召开符合《中华人民共和国公司 法》、《上市公司股东会规则》和《公司章程》的有关规定，会议合法有效。 (五)公司董事和董事会秘书的列席情况 1、公司在任董事9人，列席9人。 2、董事会秘书列席了本次会议；全体高管列席了本次会议。 (二)股东会召开的地点：四川省乐山高新区迎宾大道18号 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： 二、议案审议情况 (一)非累积投票议案 1、议案名称： ...